SARS-CoV-2 vaccination

BIOLOGICAL2 trials

Sponsors

University Medical Center Groningen, Sinai University

Conditions

Chronic Kidney DiseasesCovid19SARS CoV 2 Vaccination

Unknown Phase

The REnal Patients COVID-19 VACcination Immune Response (RECOVAC IR) Study

CompletedNCT04741386

University Medical Center GroningenChronic Kidney Diseases, Covid19

Start: 2021-02-17End: 2022-02-25Updated: 2022-04-04

Impact of COVID-19 Vaccination on Balance Function Among Adolescents: A Long-Term Perspective

CompletedNCT06503926

Sinai UniversitySARS CoV 2 Vaccination

Start: 2023-12-06End: 2024-07-01Updated: 2025-07-16

Related Papers

Patient engagement as a collaborative process in a large Dutch COVID-19 vaccination study (RECOVAC) – insight into the contribution of patient engagement and learnings for the future

Research Involvement and Engagement2024-09-132 citations

Antibody and T-Cell Responses 6 Months After Coronavirus Disease 2019 Messenger RNA-1273 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant

Clinical Infectious Diseases2022-07-0751 citations